DEFINING THE ROLE OF IMMUNOTHERAPY AND IMMUNE BIOMARKERS IN HEAD AND NECK AND CUTANEOUS SQUAMOUS CELL CARCINOMAS
Grant number: 1175929 | Funding period: 2020 - 2024
Related publications (1)
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma
Luke S McLean, Karda Cavanagh, Rodney J Hicks, Jason Callahan, Jing Xie, Anthony Cardin, Annette M Lim, Danny Rischin
BACKGROUND: The role of FDG-PET/CT imaging in assessing response to immunotherapy in advanced cutaneous squamous cell carcinoma (C..